A citation-based method for searching scientific literature

Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
Times Cited: 9







List of co-cited articles
56 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Euglycaemic diabetic ketoacidosis.
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
163
44

Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma.
Prashanth Rawla, Anantha R Vellipuram, Sathyajit S Bandaru, Jeffrey Pradeep Raj. Endocrinol Diabetes Metab Case Rep 2017
30
44

Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
14
44

Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.
Pablo Lucero, Sebastián Chapela. Case Rep Crit Care 2018
20
44


SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
295
33

SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
125
33

SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
Katherine M Wang, Robert T Isom. Kidney Med 2020
14
33


Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy.
Devon J Pace, Katerina Dukleska, Samantha Phillips, Vanessa Gleason, Charles J Yeo. J Pancreat Cancer 2018
12
33

Euglycemic Diabetic Ketoacidosis: A Review.
Anar Modi, Abhinav Agrawal, Farah Morgan. Curr Diabetes Rev 2017
82
33

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
7
42

Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.
Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
8
37

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
Fernand Bteich, Ghassan Daher, Aniruddh Kapoor, Edward Charbek, Ghassan Kamel. Cureus 2019
4
75


The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
Nellowe Candelario, Jedrzej Wykretowicz. Oxf Med Case Reports 2016
23
33

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Masafumi Fukuda, Masakazu Nabeta, Takanori Muta, Kei Fukami, Osamu Takasu. Int J Emerg Med 2020
6
50


Euglycemic DKA (euDKA) as a presentation of COVID-19.
Bhagwan Dass, Andrew Beck, Cody Holmes, Glenville Morton. Clin Case Rep 2020
5
40




AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
183
22

Euglycemic Diabetic Ketoacidosis Due to Gastroparesis, A Local Experience.
Ronillo Legaspi, Philipp Narciso. J Ark Med Soc 2015
9
22


Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus.
Iouri Banakh, Ross Kung, Sachin Gupta, Kati Matthiesson, Ravindranath Tiruvoipati. Clin Case Rep 2019
5
40



Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.
Antonios Douros, Lisa M Lix, Michael Fralick, Sophie Dell'Aniello, Baiju R Shah, Paul E Ronksley, Éric Tremblay, Nianping Hu, Silvia Alessi-Severini, Anat Fisher,[...]. Ann Intern Med 2020
38
22



A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet.
Brenda Dorcely, Juliana Nitis, Arthur Schwartzbard, Jonathan D Newman, Ira J Goldberg, Melissa Sum. Curr Diabetes Rev 2021
5
40

A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed.
Samantha Steinmetz-Wood, Matthew Gilbert, Katherine Menson. Case Rep Endocrinol 2020
7
28

Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin).
Azka Latif, Aheli Arce Gastelum, Akshat Sood, Joseph Thilumala Reddy. BMJ Case Rep 2020
3
66



Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
Sang Mok Yeo, Hayeon Park, Jin Hyuk Paek, Woo Yeong Park, Seungyeup Han, Sung Bae Park, Kyubok Jin. Medicine (Baltimore) 2019
8
25


Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis.
Iqra Iqbal, Mohsin Hamid, Muhammad Atique Alam Khan, Aleesha Kainat, Shafaq Tariq. Cureus 2019
10
22

Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
Chie Kitahara, Shuhei Morita, Shohei Kishimoto, Shohei Matsuno, Shinsuke Uraki, Ken Takeshima, Yasushi Furukawa, Hidefumi Inaba, Hiroshi Iwakura, Hiroyuki Ariyasu,[...]. J Diabetes Investig 2021
2
100

Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
An-Yi Wang, Sen-Kuang Hou, Shan-Jen Li, Wei-Fong Kao. Am J Emerg Med 2017
5
40

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
22

Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
Yu-Mou Chou, Chen-June Seak, Zhong Ning Leonard Goh, Joanna Chen-Yeen Seak, Chen-Ken Seak, Chih-Chuan Lin. Medicine (Baltimore) 2018
18
22


Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
22


Euglycemic diabetic ketoacidosis: A missed diagnosis.
Prashant Nasa, Sandeep Chaudhary, Pavan Kumar Shrivastava, Aanchal Singh. World J Diabetes 2021
8
25

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
22

Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.
Manoj R Somagutta, Kuchalambal Agadi, Namrata Hange, Molly S Jain, Erkan Batti, Bernard O Emuze, Elizabeth O Amos-Arowoshegbe, Sorin Popescu, Saad Hanan, Varadha Retna Kumar,[...]. Cureus 2021
7
28

Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.
Brit Long, Skyler Lentz, Alex Koyfman, Michael Gottlieb. Am J Emerg Med 2021
9
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.